In the obese trial cohort, 1 mg moved 24-hour heart rate by +0.7 bpm in the first week, essentially placebo. In a healthy lean Phase 1b group, the same dose raised heart rate by about 10 bpm, with a peak near 15 to 20 bpm around days 4 to 6. Lean, younger participants had more reactive heart-rate control than the sedentary, obese, and metabolically stressed trial population
Community sources describe starting conservatively at 0.25 mg 3x weekly (0.75 mg total weekly) for the first 2-4 weeks the dual GLP-1/GIP mechanism can cause more intense initial GI side effects than single-target agonists
This fixed-dose combination leverages complementary mechanisms to achieve superior weight management outcomes compared to either agent alone [5]
Week 1 to 2: Hydration improvements
Most patients complete 3 cycles before assessing full results, though skin improvements often become noticeable within the first cycle
Furthermore, those who have more resilient skin or those of an older age may find this potent combination to be an excellent pair for more transformative results